Jeffrey Leary, MD
Adult Reconstructive Orthopaedic Surgery · New Providence, NJNPI 1033314042
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $135,298 of the $148,471 with a category attached, or 91.1%. Stryker accounts for 96.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $79,939 and has fallen 90.5% since, to $7,625 in 2025.
Across 192 payments — averaging $773.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$143K
- Medical Device Business Services, Inc.$4K
- Globus Medical$600
- Ferring Pharmaceuticals Inc.$445
- Bioventus LLC$311
- Johnson & Johnson$172
- plus $162 from 3 others
What the payments were for
- Consulting fees$135,29891%
- Travel & lodging$9,1706%
- Food & beverage$4,0043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 134 | $143,026 |
| Medical Device Business Services, Inc. | 3 | $3,754 |
| Globus Medical | 2 | $600 |
| Ferring Pharmaceuticals Inc. | 26 | $445 |
| Bioventus LLC | 11 | $311 |
| Johnson & Johnson(2 entities) | 6 | $172 |
| Sanofi-aventis U.S. LLC | 5 | $85 |
| Endo Pharmaceuticals Inc. | 3 | $44 |
| Smith+Nephew | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AXSOS$101,144
- GAMMA$53,713
- T2$52,008
- VARIAX$47,462
- HOFFMANN$28,372
- AUGMENT INJECTABLE$15,513
- REUNION$10,488
- T2 ALPHA$9,825
- PELVIS II$9,100
- TRIATHLON$5,000
- PRO$5,000
- PROstep$4,250
- INBONE$4,250
- TFN ADVANCED$3,510
- DHS$3,510
- IM NAILS$3,510
- PRIME SERIES$2,600
- ALLOGRAFT BIO-IMPLANTS$1,400
- MAKO$1,337
- ADAPT$1,143
How this compares
$148,471 in reported general payments places this provider in the 80th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.
See all adult reconstructive orthopaedic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 14 | $447 |
| Amoxicillin | 171 | $274 |
| Meloxicam | 76 | $164 |
| Clindamycin Hcl | 21 | $31 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in New Providence
- Jared PrestonNew Providence$12K
- Atul KamathManasquan$4M
- Alfred TriaSomerset$582K
- John DundonHackettstown$573K
- Ismar DizdarevicRidgewood$368K
- David FeldmanEnglewood$335K
- Mark PizzurroRidgewood$239K
- Timothy HendersonWayne$140K
- Anthony CostaEatontown$95K
- Gregory RoehrigManasquan$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.